Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.

[1]  S. Miyamoto,et al.  Heparin‐binding epidermal growth factor‐like growth factor as a novel targeting molecule for cancer therapy , 2006, Cancer science.

[2]  E. Mekada,et al.  Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor. , 2006, Cell structure and function.

[3]  Kimmo J Hatanpaa,et al.  Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. , 2006, Cancer research.

[4]  A. Adjei,et al.  K-ras as a target for cancer therapy. , 2005, Biochimica et biophysica acta.

[5]  G. Giaccone,et al.  EGFR inhibitors in lung cancer. , 2005, Oncology.

[6]  Ho-Yyoung Lee,et al.  Resistance to epidermal growth factor receptor-targeted therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[7]  E. Mekada,et al.  HB-EGF promotes epithelial cell migration in eyelid development , 2005, Development.

[8]  Satoshi O. Suzuki,et al.  Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer , 2005, Clinical Cancer Research.

[9]  E. Mekada,et al.  Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.

[10]  H. Lane,et al.  ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.

[11]  S. Miyamoto,et al.  Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer , 2005, British Journal of Cancer.

[12]  T. Joh,et al.  IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. , 2005, Cytokine.

[13]  Thomas S Deisboeck,et al.  The effects of EGF-receptor density on multiscale tumor growth patterns. , 2005, Journal of theoretical biology.

[14]  R. Nicholson,et al.  Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. , 2004, Endocrine-related cancer.

[15]  M. Klagsbrun,et al.  Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) is a Mediator of Multiple Physiological and Pathological Pathways , 2004, Growth factors.

[16]  Joseph Schlessinger,et al.  Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors , 2004, Science.

[17]  J. Settleman.  Inhibition of Mutant EGF Receptors by Gefitinib: Targeting an Achilles’ Heel of Lung Cancer , 2004, Cell cycle.

[18]  M. Fujimoto,et al.  Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Daniel A. Haber,et al.  Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways , 2004, Science.

[20]  M. Kai,et al.  Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy , 2004, Cancer Research.

[21]  P. Ongusaha,et al.  HB-EGF Is a Potent Inducer of Tumor Growth and Angiogenesis , 2004, Cancer Research.

[22]  Y. Yarden,et al.  Oncogenic growth factor receptors: implications for signal transduction therapy. , 2004, Seminars in cancer biology.

[23]  P. LoRusso,et al.  Targeting the epidermal growth factor receptor , 2004, British Journal of Cancer.

[24]  C. Morisi,et al.  CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients , 2004, Cancer Immunology, Immunotherapy.

[25]  R. Harris,et al.  Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells , 2004, Journal of Cell Science.

[26]  M. Romano,et al.  Helicobacter pyloriγ‐glutamyltranspeptidase upregulates COX‐2 and EGF‐related peptide expression in human gastric cells , 2004, Cellular microbiology.

[27]  R. Romero,et al.  Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. , 2004, Developmental biology.

[28]  S. Higashiyama,et al.  Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor. , 2004, Cytokine & growth factor reviews.

[29]  A. Ullrich,et al.  Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion , 2004, Oncogene.

[30]  A. Ullrich,et al.  EGFR signal transactivation in cancer cells. , 2003, Biochemical Society transactions.

[31]  Y. Kaneda,et al.  Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities , 2003, The Journal of cell biology.

[32]  A. Mammoto,et al.  Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF , 2003, The Journal of cell biology.

[33]  David C. Lee,et al.  Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.

[34]  E. Mekada,et al.  The Stress- and Inflammatory Cytokine-induced Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor Is Mediated by p38 MAPK, Distinct from the 12-O-Tetradecanoylphorbol-13-acetate- and Lysophosphatidic Acid-induced Signaling Cascades* , 2003, The Journal of Biological Chemistry.

[35]  M. Washington,et al.  Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. , 2003, Gastroenterology.

[36]  Hironobu Nakayama,et al.  Possible chemoresistance‐related genes for gastric cancer detected by cDNA microarray , 2003, Cancer science.

[37]  Masatsugu Hori,et al.  Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Normanno,et al.  Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. , 2003, Endocrine-related cancer.

[39]  S. Dey,et al.  Pre-eclampsia and expression of heparin-binding EGF-like growth factor , 2002, The Lancet.

[40]  A. Mammoto,et al.  Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin‐binding epidermal growth factor‐like growth factor (HB‐EGF) , 2002, Journal of cellular physiology.

[41]  A. Ullrich,et al.  Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. , 2002, Biochemical and biophysical research communications.

[42]  Helmut Burtscher,et al.  Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis. , 2002, Anticancer research.

[43]  A. Ganser,et al.  Tumor suppressor genes in normal and malignant hematopoiesis , 2002, Oncogene.

[44]  J. D. Vos,et al.  Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells , 2002, Oncogene.

[45]  M. Nistér,et al.  TGF-α-Driven Tumor Growth Is Inhibited by an EGF Receptor Tyrosine Kinase Inhibitor , 2002 .

[46]  R. Peek,et al.  cag+ Helicobacter pylori Induce Transactivation of the Epidermal Growth Factor Receptor in AGS Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[47]  Y. Lu,et al.  Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). , 2001, Journal of the National Cancer Institute.

[48]  S. Poulsen,et al.  A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. , 2001, Cancer research.

[49]  E. Mekada,et al.  A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor* , 2001, The Journal of Biological Chemistry.

[50]  M. Freeman,et al.  BAG-1 Is a Novel Cytoplasmic Binding Partner of the Membrane Form of Heparin-binding EGF-like Growth Factor , 2001, The Journal of Biological Chemistry.

[51]  A. Prat,et al.  N‐arginine dibasic convertase is a specific receptor for heparin‐binding EGF‐like growth factor that mediates cell migration , 2001, The EMBO journal.

[52]  M. Monden,et al.  Expression of heparin binding epidermal growth factor-like growth factor in hepatocellular carcinoma: an immunohistochemical study. , 2001, Oncology reports.

[53]  E. Mekada,et al.  Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF. , 2001, Biochemical and biophysical research communications.

[54]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[55]  E. Mekada,et al.  Heparin-binding EGF-like growth factor: a juxtacrine growth factor. , 2000, Cytokine & growth factor reviews.

[56]  K. L. Pierce,et al.  Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells* , 2000, The Journal of Biological Chemistry.

[57]  B. Groner,et al.  Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo , 2000, International journal of cancer.

[58]  D. Jayne,et al.  Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases , 2000, British Journal of Cancer.

[59]  E. Mekada,et al.  Contact-dependent Growth Inhibition and Apoptosis of Epidermal Growth Factor (EGF) Receptor-expressing Cells by the Membrane-anchored Form of Heparin-binding EGF-like Growth Factor* , 1999, The Journal of Biological Chemistry.

[60]  David C. Lee,et al.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.

[61]  P. Vogt,et al.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. , 1999, Development.

[63]  K. Mishima,et al.  Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas , 1998, Acta Neuropathologica.

[64]  M Markman,et al.  Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.

[65]  M. Klagsbrun,et al.  Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin‐binding EGF‐like growth factor independently of protein kinase C , 1998, Journal of cellular biochemistry.

[66]  D. Stern,et al.  Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[67]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[68]  S. Oldham,et al.  A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[69]  M. Klagsbrun,et al.  Activation of HER4 by heparin‐binding EGF‐like growth factor stimulates chemotaxis but not proliferation , 1997, The EMBO journal.

[70]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[71]  H. Friess,et al.  Co‐expression of heparin‐binding EGF‐like growth factor and related peptides in human gastric carcinoma , 1996, International journal of cancer.

[72]  M. Klagsbrun,et al.  Heparin-like Molecules on the Cell Surface Potentiate Binding of Diphtheria Toxin to the Diphtheria Toxin Receptor/Membrane-anchored Heparin-binding Epidermal Growth Factor-like Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[73]  Carmen Birchmeier,et al.  Multiple essential functions of neuregulin in development , 1995, Nature.

[74]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[75]  Rüdiger Klein,et al.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.

[76]  M. Klagsbrun,et al.  Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. , 1995, Molecular biology of the cell.

[77]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[78]  E. Mekada,et al.  Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites , 1995, The Journal of cell biology.

[79]  M. Klagsbrun,et al.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.

[80]  John Calvin Reed,et al.  Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity , 1995, Cell.

[81]  T. Mitamura,et al.  Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity (*) , 1995, The Journal of Biological Chemistry.

[82]  H. Friess,et al.  Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. , 1994, Biochemical and biophysical research communications.

[83]  H. Asada,et al.  Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. , 1994, The Journal of biological chemistry.

[84]  T. Mitamura,et al.  Heparin‐binding EGF‐like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up‐regulates functional receptors and diphtheria toxin sensitivity. , 1994, The EMBO journal.

[85]  N. Normanno,et al.  Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.

[87]  D. Russell,et al.  Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.

[88]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[89]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[90]  G. Mills,et al.  A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. , 1988, Cancer research.

[91]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[92]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[93]  S. Buzzi.  Diphtheria toxin treatment of human advanced cancer. , 1982, Cancer research.

[94]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[95]  T. Uchida,et al.  Mutation in the structural gene for diphtheria toxin carried by temperate phage . , 1971, Nature: New biology.

[96]  E. Mekada,et al.  Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia. , 2005, Cell structure and function.

[97]  D. Seals,et al.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions. , 2003, Genes & development.

[98]  K. Wakasa,et al.  Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma , 2001, International journal of pancreatology : official journal of the International Association of Pancreatology.

[99]  P. A. Harding,et al.  Induction of anchorage independent growth by heparin-binding EGF-like growth factor (HB-EGF). , 1999, Growth factors.

[100]  S. Yamashita,et al.  Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[101]  J. Massagué,et al.  Membrane-anchored growth factors. , 1993, Annual review of biochemistry.